1-4 of 4
Allison Keshishian, MPH
Close
Sort by
Journal Articles

Effectiveness and Safety of Apixaban Vs Warfarin Among Venous Thromboembolism Patients Using Five US Databases: A Subgroup Analysis of Obesity

Alexander T Cohen, MBBS MSc MDFRACP FESC, Janvi Sah, MS, Theodore Lee, MD, Gail Wygant, RN, Lisa Rosenblatt, MD MPH, Patrick Hlavacek, MPH, Birol Emir, PhD, Allison Keshishian, MPH, Rachel Delinger, MPH, Xuemei Luo, PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 1.
https://doi.org/10.1182/blood-2020-140453
Published: 2020
Journal Articles

Real-World Patterns of Care for Patients with Follicular Lymphoma Treated with Lenalidomide and Rituximab (R 2 ) in the US Medicare Population

Scott Huntington, MDMPH, Allison Keshishian, MPH, Lin Xie, MA, MS, Onur Baser, MS, PhD, Michael McGuire, PharmD
Journal: Blood
Blood (2017) 130 (Supplement 1): 4706.
https://doi.org/10.1182/blood.V130.Suppl_1.4706.4706
Published: 2017
Journal Articles

Evaluating the Economic Burden and Health Care Utilization Following First-Line Therapy for Diffuse Large B-Cell Lymphoma Patients in the US Medicare Population

Scott F Huntington, MDMPH, Allison Keshishian, MPH, Lin Xie, MA, MS, Onur Baser, MS, PhD, Michael McGuire, PharmD
Journal: Blood
Blood (2016) 128 (22): 3574.
https://doi.org/10.1182/blood.V128.22.3574.3574
Published: 2016
Journal Articles

Early Comparison of Major Bleeding, Stroke and Associated Medical Costs Among Treatment-Naive Non-Valvular Atrial Fibrillation Patients Initiating Apixaban, Dabigatran, Rivaroxaban or Warfarin

Amin N Alpesh, MBA, MD, Allison Keshishian, MPH, Lin Xie, MA, MS, Onur Baser, MS, PhD, Kwanza Price, MPH, Lien Vo, MPH, PharmD, Prianka Singh, PharmD, Amanda Bruno, MPH, PhD, Jack Mardekian, PhD, Wilson Tan, MRCS, MD, Shalabh Singhal, MD, Chad Patel, PharmD, Kevin Odell, PharmD, Jeffrey Trocio, MPH
Journal: Blood
Blood (2015) 126 (23): 745.
https://doi.org/10.1182/blood.V126.23.745.745
Published: 2015